Calliditas Therapeutics AB (publ)
CALT · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $974 | $1,249 | $956 | $996 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $188 | $81 | $0 | $0 |
| Inventory | $20 | $4 | $1 | $0 |
| Other Curr. Assets | $93 | $78 | $56 | $41 |
| Total Curr. Assets | $1,275 | $1,412 | $1,013 | $1,037 |
| Property Plant & Equip (Net) | $54 | $32 | $40 | $5 |
| Goodwill | $49 | $46 | $37 | $445 |
| Intangibles | $431 | $438 | $362 | $16 |
| Long-Term Investments | $24 | $11 | $4 | $2 |
| Tax Assets | $68 | $14 | $4 | $1 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $625 | $541 | $447 | $470 |
| Other Assets | $0 | -$0 | $0 | $0 |
| Total Assets | $1,901 | $1,953 | $1,460 | $1,506 |
| Liabilities | – | – | – | – |
| Payables | $101 | $160 | $68 | $54 |
| Short-Term Debt | $13 | $0 | $0 | $0 |
| Tax Payable | $6 | $6 | $1 | $1 |
| Deferred Revenue | $6 | $136 | $3 | -$4 |
| Other Curr. Liab. | $288 | $159 | $63 | $51 |
| Total Curr. Liab. | $407 | $325 | $135 | $106 |
| LT Debt | $967 | $729 | $213 | $1 |
| Deferred Rev, NC | $27 | $4 | $18 | -$1 |
| Deferred Tax Liab, NC | $83 | $40 | $31 | $80 |
| Other NC Liab. | $150 | $93 | $72 | $101 |
| Total NC Liab. | $1,159 | $861 | $316 | $145 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $27 | $16 | $24 | $1 |
| Total Liabilities | $1,566 | $1,187 | $452 | $250 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $2 | $2 | $2 | $2 |
| Retained Earnings | -$2,306 | -$1,827 | -$1,454 | -$919 |
| AOCI | -$5 | $9 | -$27 | -$6 |
| Other Equity | $2,643 | $2,591 | $2,462 | $2,133 |
| Total Equity | $335 | $766 | $1,008 | $1,210 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $46 |
| Total Liab. & Tot. Equity | $1,901 | $1,953 | $1,460 | $1,506 |
| Net Debt | $5 | -$520 | -$742 | -$995 |